Cleveland, OH 的 小細胞肺癌 臨床試驗
13 項針對 小細胞肺癌 的研究正在 Cleveland（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
招募中2 期
- University Hospitals Cleveland Medical Center /ID# 277556, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- The Cleveland Clinic Taussig Cancer Center, Cleveland
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
招募中2/3 期
- University Hospitals Cleveland Medical Center, Cleveland
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
招募中1/2 期
- University Hospitals Cleveland Medical Center, Cleveland
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中1/2 期
- University Hospitals Cleveland Medical Center, Cleveland
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
招募中3 期
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic - Fairview Hospital Molly Pavilion, Cleveland
- Cleveland Clinic, Cleveland
- 還有 1 項
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
招募中3 期
- University Hospitals Cleveland Medical Center, Cleveland
- The Cleveland Clinic Cancer Center at Fairview Hospital, Moll Pavilion, Cleveland
- Cleveland Clinic Foundation, Cleveland
- 還有 1 項
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
招募中1/2 期
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
招募中2 期
- University Hospital - Cleveland Medical Center, Cleveland
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
招募中2 期
- Cleveland Clinic, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- Cleveland Clinic, Cleveland
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
招募中1 期
- Case Comprehensive Cancer Center, Cleveland
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
招募中1 期
- Zelgen Site 104, Cleveland
其他城市的 小細胞肺癌 試驗
- Houston, TX26 項研究
- Arlington, VA23 項研究
- New York City, NY22 項研究
- Boston, MA21 項研究
- Los Angeles, CA20 項研究
- Nashville, TN20 項研究
- Orlando, FL15 項研究
- Dallas, TX13 項研究
- Chicago, IL13 項研究
- St. Louis, MO13 項研究
- Detroit, MI12 項研究
- Washington, DC12 項研究
Cleveland 的其他研究
- 非小細胞肺癌43 項研究
- 癌症（所有類型）36 項研究
- 乳癌35 項研究
- 前列腺癌34 項研究
- 心臟衰竭33 項研究
- 卵巢癌30 項研究
- 轉移性癌症30 項研究
- 肺癌26 項研究
- 大腸直腸癌24 項研究
- 心血管疾病22 項研究
- 子宮內膜癌20 項研究
- 急性髓系白血病20 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。